Acquiring Company
Kincell Bio
Acquired Company
Cellipont Bioservices
Description
Kincell Bio and Cellipont Bioservices have completed their merger to form Kincellis Advanced Therapies. This new entity focuses on developing cell therapies and advanced modalities. The merger combines Kincell's expertise in immune-cell technologies with Cellipont's stem cell experience. Kincellis Advanced Therapies will enhance capabilities in the field of regenerative medicine.
Don't miss Kincell Bio's next move
Get an email the moment Kincell Bio makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Cellipont Bioservices?
Cellipont Bioservices was acquired by Kincell Bio, based in Durham. The deal was reported on September 17, 2026. Kincell Bio is a technology-forward cell therapy cGMP contract development and manufacturing organization (CDMO) situated in the Southeastern United States. Kincell Bio is privately held and operates in Manufacturing.
When did Kincell Bio acquire Cellipont Bioservices?
Kincell Bio's acquisition of Cellipont Bioservices was reported on September 17, 2026. Kincell Bio and Cellipont Bioservices have completed their merger to form Kincellis Advanced Therapies. This new entity focuses on developing cell therapies and advanced modalities. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Cellipont Bioservices do?
Cellipont Bioservices is a premier Contract Development and Manufacturing Organization (CDMO) specializing in the advancement of cell therapies. It is privately held, operating in Manufacturing, and is based in The Woodlands.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.